Replies to post #110456 on Innovation Pharmaceuticals Inc (IPIX)

[F1ash]

Just for the sake of keeping the details straight, not all of the (65 lbs) was transferred for testing by a medical device maker.

"We are now in the process of manufacturing 30 kg of Brilacidin for future clinical trials which we plan for multiple forms of serious infections.”

"Looking to Brilacidin, the lead drug candidate in the Company’s definsin-mimetic platform, Cellceutix has signed an agreement with a division of one of the largest U.S. pharmaceutical companies for testing Brilacidin as a component of certain implanted devices as a means to prevent infection"

http://cellceutix.com/cellceutix-completes-enrollment-in-phase-2b-clinical-trial-of-brilacidin-for-acute-bacterial-skin-and-skin-structure-infections-absssi/#sthash.sQZlaqfa.dpbs